ConductScience.org, home

Paper87869

Progression of retinopathy long after cessation of chloroquine therapy.

Ogawa S and 3 others. Lancet, 1979. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Progression of retinopathy long after cessation of chloroquine therapy. Papers, record 87869. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/87869

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Progression of retinopathy long after cessation of chloroquine therapy.
PubMed
Journal
Lancet
PubMed
Year
1979
PubMed
Publication types
Letter
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
1.3
iCite
Revised in PubMed
2019-06-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ogawa SS
2Kurumatani NN
3Shibaike NN
4Yamazoe SS

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ChloroquineMajor topic
Visual AcuityMajor topic
Adult
Aged
Collagen Diseases
Female
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
39803390Optical coherence tomography characteristics in hydroxychloroquine retinopathy and the correlations with visual deterioration in Taiwanese.Taiwan J Ophthalmol2024https://conductscience.org/library/papers/39803390PubMed
38565930An observational study to identify causative factors for not using hydroxychloroquine in systemic lupus erythematosus.Sci Rep2024https://conductscience.org/library/papers/38565930PubMed
34014447Ocular findings in Japanese patients with hydroxychloroquine retinopathy developing within 3 years of treatment.Jpn J Ophthalmol2021https://conductscience.org/library/papers/34014447PubMed
32934892Quantitative Fundus Autofluorescence in Systemic Chloroquine/Hydroxychloroquine Therapy.Transl Vis Sci Technol2020https://conductscience.org/library/papers/32934892PubMed
27847636Expanded spectral domain-OCT findings in the early detection of hydroxychloroquine retinopathy and changes following drug cessation.Int J Retina Vitreous2016https://conductscience.org/library/papers/27847636PubMed
6356101Adverse ocular reactions to drugs.Postgrad Med J1983https://conductscience.org/library/papers/6356101PubMed
3964626Delayed-onset chloroquine retinopathy.Br J Ophthalmol1986https://conductscience.org/library/papers/3964626PubMed
3929938Screening for antimalarial maculopathy in rheumatology clinics.Br Med J (Clin Res Ed)1985https://conductscience.org/library/papers/3929938PubMed
2275937Is thioridazine retinopathy progressive? Relationship of pigmentary changes to visual function.Br J Ophthalmol1990https://conductscience.org/library/papers/2275937PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/87869

GET https://conductscience.org/api/papers/v1/87869/authors